BRADFORD GEYER – ATTORNEY IN THE CLASS ACTION REMDESIVIR LAWSUIT– 10 21 23

THE COMPANY THAT MANUFACTURES REMDESIVIR, USED ACROSS THE UNITED STATES TO TREAT COVID-19, HAS BEEN HIT WITH A CLASS-ACTION LAWSUIT OVER ALLEGATIONS IT DECEPTIVELY PROMOTED THE DRUG WITHOUT DISCLOSING POSSIBLE SIDE EFFECTS. WE SPEAK WITH BRADFORD GEYER, AN ATTORNEY WITH FORMER FEDS GROUP WHO ARE REPRESENTING THE PLAINTIFFS.